Among patients with obstructive sleep apnea treated with continuous positive airway pressure therapy, those with resistant hypertension may enjoy de-escalation or reduction in medical therapy.
Role of UPPP in Sleep Apnea

Uvulopalatopharyngoplasty in the Management of Obstructive Sleep Apnea: The Mayo Clinic Experience.
Khan A, Ramar K, et al: Mayo Clin Proc 2009; 84 (September): 795-800 Milder degree of obstructive sleep apnea and lower body mass index have a better chance of responding to uvulopalatopharyngoplasty.
Objective: To assess the role of uvulopalatopharyngoplasty (UPPP) in the treatment of obstructive sleep apnea (OSA). Design/Methods: Retrospective analysis of patients of patients aged ≥18 years who were diagnosed with OSA and treated with UPPP between January 1, 1988, and August 31, 2006 . Patients included in this report had undergone polysomnography within 6 months before and after UPPP. Board-certified specialists in sleep disorders evaluated all cases. Hypopnea was defined as a 30% decrease in airflow for at least 10 seconds and a decrease in saturation of 2%. As of May 1, 2002, the desaturation criterion was changed to ≤4% to comply with the Centers for Medicare and Medicaid Services continuous positive airway pressure (CPAP) coverage requirements. OSA was defined as cessation of airflow for at least 10 seconds despite respiratory effort. Results: 63 patients met study requirement criteria; 51 were men. Studies were done up to 97 days before and 122 days after UPPP. A mean reduction of 54.4% in the apnea-hypopnea index (AHI) was achieved, as well as a 38.4% decrease in mean arousal index with an improvement in time spent with an oxygen level <90%. Using the criteria of achieving a ≥50% decrease in AHI and/or an absolute AHI of ≤20 resulted in a 51% success rate. Using an AHI of ≤10 resulted in a success rate of 33%. Using an even more stringent criterion of an AHI of ≤5 resulted in a success rate of 23.8%. Four of 5 patients with a body mass index (BMI) of ≤25 achieved a post-UPPP AHI of ≤5. Ten of 17 patients with a BMI of ≤30 achieved an AHI of ≤5. However, only 5 of 46 patients with a BMI of >30 reached the ≤5 level. Of 48 patients who did not reach the ≤5 level, 13 chose weight reduction and positional therapy as opposed to CPAP; the other 35 accepted CPAP. Conclusions: In an unselected group of patients with OSA, UPPP leads to a low rate of success if success is defined as a postoperative AHI of ≤5 or ≤10. Greater success is seen in those who have milder OSA and a BMI of ≤30. Reviewer's Comments: This study is of great importance if we are to look at "value" when treating patients with UPPP for OSA. Although outcome is the most important measure of success in any given patient, the likelihood of success must be ascertained before exposing a patient to the risk of surgery. Predictable poor outcome is not wise use of health care dollars. (Reviewer-Allan R. Goldstein, MD). There is a downregulation of the affect-related insular cortex activity by the PAG during the perception of dyspnea and pain in patients with asthma.
Asthmatics Habituate to Dyspnea
Down-Regulation of Insular Cortex Response to Dyspnea and Pain in Asthma.
Objective:
To establish a possible neural mechanism that might be responsible for varying degrees of dyspnea in asthmatic patients. Participants: The patient group consisted of 14 subjects with mild-to-moderate asthma. They were matched by gender and age to 14 healthy individuals. All patients in both groups were free from major respiratory causes or difficulties for 4 weeks preceding the study. Methods: Asthmatics were required to refrain from taking medication except for the inhaled steroids for 16 hours prior to the study. Dyspnea was created by breathing through an inspiratory flow resistance device. Standard respiratory parameters were measured during the testing. Dyspnea was measured using a Borg scale. After each measurement, the patients also rated the sensory intensity or pain associated with the resistive load using another horizontal scale. At this point in time, patients also underwent a functional brain scan using magnetic resonance. Results: Except for lung function abnormalities, there were no differences between control subjects and test subjects. All subjects demonstrated an increase in perceived sensory intensity of both dyspnea and pain from the mild to the severe obstruction. However, the unpleasantness of the sensation of dyspnea was significantly reduced in the asthmatics when compared to the control subjects. Patients with asthma demonstrated reduced signal intensity in the insular cortex of the brain. This was associated with a greater increase than the controls in the periaqueductal gray area. Psychophysiological interaction analysis revealed that the increased periaqueductal gray (PAG) activation moderated the reduced insular activation in the asthmatic patients with increasing dyspnea. Conclusions: There is a downregulation of the affect-related insular cortex activity by the PAG during the perception of dyspnea and pain in patients with asthma. The authors postulate that this might represent a habituation to reduce the unpleasantness of the often-felt dyspnea in patients with asthma similar to what happens in patients who have chronic pain. Reviewer's Comments: These data may help explain why we have such variability in patients presenting to the ED with symptoms of asthma. Some patients wait until the last possible moment, while others present significantly earlier. It may well be that habituation to symptoms of dyspnea in certain asthmatic patients may, in fact, be due to the detriment in the lack of perception of how sick they really are. This delay in seeking attention could result in significant morbidity as well as possible mortality. (Reviewer-Eric H. Gluck, MD, JD).
